ArticleEndocrine-related cancer2019
177Lu-octreotate therapy for neuroendocrine tumours is enhanced by Hsp90 inhibition.
Tobias Hofving et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it
ArticleEndocrine-related cancer2019
Tobias Hofving et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.